The financials
Kestra Medical Technologies, Ltd. by the numbers
Kestra Medical Technologies, Ltd. (KMTS) reported revenue of $29M in Q4 2026 (quarter ended April 30, 2026), up 66% from the same quarter a year earlier. That came with a gross margin of 55% and net loss of $39M. For the full year FY2026, revenue was $95M (+59% year on year) and net income −$132M.
| Income statement | Q4 2026 | Q4 2025 | Change |
|---|---|---|---|
| Revenue | $29M | $17M | +66% |
| Gross profit | $16M | $7.6M | +105% |
| Operating income | −$39M | −$48M | n/a |
| Net income | −$39M | −$52M | n/a |
| Diluted EPS | −$0.67 | −$1.57 | n/a |
Medical Instruments & Supplies
Ranks #26 of 27 by Smart Score